Deep Brain Stimulation Market, By End-user (Hospitals, Ambulatory Surgical Centers, Neurological Clinics, and Others), By Application (Parkinson's Disease, Epilepsy, Essenmarkettial Tremor, Dystonia, Obsessive Compulsive Disorder, and Others), By Region Analysis - Global Analysis And Industry Forecast Report Till 2030.

The Deep Brain Stimulation Market is projected to grow from $1.16 billion to $2.67 billion, at a CAGR of 9.7% during the forecast period 2021-2030.

Deep brain stimulation is defined as surgery to implant electrical devices into the body. The device works by sending electrical signals to areas of the brain responsible for body movement. Deep brain stimulation instruments are also used to describe tools used to track brain stimulation. Many neurological conditions, including Parkinson's disease, epilepsy, essential tremor, dystonia, and obsessive-compulsive disorder, are treated with the aid of these devices.

Deep Brain Stimulation (DBS) is a revolutionary neurosurgical procedure that involves the implantation of a small device in the brain to provide therapeutic brain stimulation. Primarily used in the treatment of conditions such as Parkinson's disease, DBS surgery has shown promising results in alleviating symptoms and improving patients' quality of life. This brain stimulation therapy involves precise targeting of specific brain regions using a deep brain stimulation device, which delivers electrical impulses to regulate abnormal neural activity. While the success rate of deep brain stimulation varies depending on the individual and the condition being treated, studies have demonstrated its effectiveness in managing symptoms and reducing medication needs. However, it's important to consider factors such as deep brain stimulation cost, as the procedure can be expensive. Additionally, like any surgery, deep brain stimulation surgery carries the potential for side effects, including infection and device-related complications. Nevertheless, the benefits of DBS, particularly in addressing conditions like Parkinson's and depression, highlight its potential as a transformative treatment option.

By electrically stimulating regions close to the spine, deep brain stimulation devices can also be utilised to inhibit pain signals. The increase in the prevalence of lifestyle-related diseases such as depression and chronic pain, the increase in nervous system diseases, and investments in nervous system R&D are factors boosting the growth of the market.

Market Dynamics:

Drivers:

The increasing prevalence of Parkinson's disease is expected to boost the demand for DBS devices. According to the Parkinson's Foundation, as of 2022, more than 10 million people across the globe will have Parkinson's disease. A study published by the organization found that the incidence of PD increases with age, with only 4% of people diagnosed with PD before the age of 50. According to the same source, the incidence of Parkinson's disease in the United States by 2021 will reach 60,000 per year. These are the major spurring factors of Deep Brain Stimulation Market.

Restraints:

One of the major factors impeding the growth of the global deep brain stimulation market is the risks associated with deep brain stimulation procedures such as lead misplacement and brain hemorrhage. The primary power and configurable component of a DBS device is an implantable pulse generator. The use of deep brain stimulation devices for Parkinson's disease is expected to be limited by the risk of infection with IPG. Therefore, healthcare personnel needs to increase their knowledge of the use of adhesive sutures and low-profile devices, as well as antimicrobial impregnations and concomitant administration.

Opportunities:

Key players in market are focusing on launching upgraded versions of DBS devices already approved in the market. Parkinson’s Disease is ready to consider advanced therapies such as deep brain stimulation or implantable drug pumps and recognizes when patients need to make adjustments to their treatment. This regimen is recommended when oral medications no longer adequately relieve motor symptoms such as spasticity, slow movement, falls and dizziness, freezing, muscle spasms, and dystonia. These are the factors propelling the Deep Brain Stimulation Market growth.

Key Players:

• Abbott

• Medtronic

• Boston Scientific Corporation

• Aleva Neurotherapeutics S.A.

• Nexstim

• LivaNova PLC

• Neuropace Inc.

Market Segmentation:

Deep Brain Stimulation Market, By Application

• Parkinson's Disease

• Epilepsy

• Essential Tremor

• Dystonia

• Obsessive Compulsive Disorder

• Others

 Deep Brain Stimulation Market, By End-user

• Hospitals

• Ambulatory Surgical Centers

• Neurological Clinics

• Others

 Deep Brain Stimulation Market, By Region Type

• North America 

• Europe 

• Asia-Pacific 

• LAMEA 

Regional Analysis:

North America dominated the market with the largest share in 2021. This is owing to an increase in government funding and awareness-raising initiatives for Parkinson's disease (PD). Additionally, increasing FDA approvals for deep brain stimulants for the treatment of PD are contributing to Deep Brain Stimulation Market growth.

Asia Pacific is expected to significantly drive the market in the future from 2021 to 2030. This is attributed to increasing prevalence of neurodegenerative diseases along with the unmet demand for effective and long-term solutions. Increasing awareness of neurological disease treatment options and improving clinical development frameworks in emerging economies are expected to drive growth in this region. Additionally, high growth opportunities in developing countries such as Japan, China, and India are likely contributing to the market growth.

Scope of the report:

User

Tab Content